EPO and myeloproliferative disorder: One study demonstrated that erythroid colony formation in the absence of erythropoietin, a reliable indicator of MPN in the pre-JAK2 V617F era, was present in 16 out of 20 patients with BCS, most of whom were young women (18 to 45 years old) [6].